High-density lipoprotein and atheroma monitoring.

E Murat Tuzcu, Stephen J Nicholls

Journal: Current opinion in cardiology 2008;23(4):386-92

PMID: 18520724

Abstract

PURPOSE OF REVIEW

To highlight the use of arterial wall imaging to evaluate the impact of therapies that promote high-density lipoproteins.

RECENT FINDINGS

High-density lipoproteins possess a number of biological properties, which have a direct impact on the extent and composition of atherosclerosis. Arterial wall imaging has been employed to demonstrate the beneficial influence on atherosclerosis of a number of therapeutic agents that modify high-density lipoprotein.

SUMMARY

Atheroma imaging has become an integral component of the clinical development of novel therapeutic agents designed to promote the atheroprotective activity of high-density lipoprotein.

Address: Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.